抗人组织金属蛋白酶抑制剂—1核酶的体外制备和活性鉴定

研究了特异切割人瘢痕组织中组织金属蛋白酶抑制剂 1(tissueinhibitorofmetalloproteinases 1,TIMP 1)的锤头状核酶 ,测定了其体外切割活性。制备特异切割TIMP 1的U6snRNA嵌合型核酶基因克隆。TIMP 1mRNA基因片段克隆至T载体。用体外转录法大量制备以 [α 3 2 P]UTP标记的核酶及靶RNA ,进行体外切割实验。结果表明 :核酶∶底物 =1∶1时 ,活性的U6snRNA嵌合型核酶 (U6Rz35 8)在 5 0℃具有最佳切割活性 ,切割效率为 76 .34% ;37℃时 ,切割效率为 5 5 .2 1%。5 0℃时 ,Km=39.6nmol/L ,kcat=0 .2 1min-1;而点突变型核酶U6Rz35 8m 没有切割活性。制备的U6 Rz35 8有良好的特异切割活性 ,有望在瘢痕成纤维细胞内抑制人TIMP 1的表达。     

抗肿瘤细胞多药抗性基因MDR1和MRP1双靶位自剪切核酶的合成及其在体外活性研究

多药耐药基因MDR1和 (或 )MRP1过度表达是引起肿瘤细胞对化疗药物产生多重耐药性的重要原因 .在以往研究抗MDR1基因的核酶 (196MDR1 Rz)的基础上 ,合成了针对MRP1基因 2 10和 730编码子的核酶 (2 10MRP1 Rz ,730MRP1 Rz) ,同时利用RNA二级结构分析程序mfold 3 0设计合成了一种双靶位自剪切核酶体系 (Coat) .将 196MDR1 Rz和 2 10MRP1 Rz基因同时载入到该体系中 ,建立了抗MDR1 MRP1双靶位核酶 .在无细胞体系中对上述核酶进行的生物活性实验表明 ,2 10MRP1 Rz与 730MRP1 Rz相比能够更有效地切割底物 ;载入Coat的抗MDR1和MRP1核酶均能得以有效释放 ,同时切割各自的靶RNA序列 ,切割效率与单靶位核酶一致 ;串联核酶的先后顺序不影响切割活性     

锤头状核酶对转化生长因子β1 RNA的体外剪切作用

为研究转化生长因子β1（TGFβ1）在造血调控中的关键作用, 构建针对抗转化生长因子β1的锤头状核酶, 并对它的体外剪切活性进行探讨. TGFβ1 cDNA部分基因片段其克隆入T载体中, ３２Ｐ标记TGFβ1体外转录物, 变性的聚丙烯酰胺凝胶电泳纯化获得靶RNA.计算机设计抗TGFβ1的锤头状核酶, 并把合成的核酶基因片段克隆入pGEM-9Zf(-)中T7启动子的下游, 凝胶电泳纯化回收３２Ｐ标记核酶的体外转录物.在不同条件下进行核酶的剪切反应, 变性PAGE, 放射自显影.活性的Rz445在37℃时具有良好活性, Km为29.55 nmol/L, Kcat为0.1533 min－1, 突变型核酶Rz445m没有剪切活性.制备的Rz445在体外具有良好的特异催化剪切活性, 并有望胞内抑制TGFβ1表达, 从而在干细胞移植中应用.     

细胞周期蛋白D1特异性核酶表达载体的构建及其活性

应用mfold程序对锤头状核酶(ribozyme,Rz)和大鼠细胞周期蛋白(cyclin)D1基因的二级结构进行分析,设计合成锤头状Rz基因,通过RT-PCR扩增获得大鼠细胞周期蛋白D1目的基因,将Rz基因和细胞周期蛋白D1基因分别克隆入载体pGEM-3Zf( )中,体外转录Rz基因和靶基因并进行切割实验;将Rz基因与逆转录病毒载体pLXSN重组得到Rz真核表达载体pLXSN-Rz,将其转染入HSC-T6细胞,G418筛选出阳性细胞克隆,用RT-PCR检测细胞周期蛋白D1基因的表达。结果显示:针对目的基因的832位点设计合成了Rz832,成功获得Rz832基因、细胞周期蛋白D1mRNA的体外转录载体pGEM3Zf-Rz832和pGEM3Zf-cD1,经体外转录出Rz832(105nt)及细胞周期蛋白D1mRNA(1079nt)。体外切割实验证实Rz832能够特异性切割细胞周期蛋白D1mRNA,产生1014nt和65nt的切割产物,切割效率为80%。所构建的pLXSN-Rz832经酶切电泳、PCR鉴定显示,插入的Rz832序列大小约为57bp,与预期结果相同,经测序证实Rz832序列正确。转染pLXSN-Rz832的肝星状细胞(hepaticstellatecells,HSCs)细胞周期蛋白D1mRNA的表达受到明显抑制,仅为对照组的42.22%(t=-193.443,P<0.01),结果表明:Rz832能够在体外特异性切割细胞周期蛋白D1mRNA、并在HSC-T6细胞内有效抑制细胞周期蛋白D1基因的表达。     

转基因油菜中核酶介导的对花椰菜花叶病毒的高度抗病性

设计了特异切割花椰菜花叶病毒(CaMV,ds DNA病毒)35S RNA的锤头型核酶基因(Rz);同时将核酶保守区内的一个G碱基以U代替构成核酶突变体(mRz)作为对照.体外切割实验表明.Rz可按设计要求高效特异地切割355 RNA,而mRz则完全没有切割活性.将Rz和mRz克隆到pROK2构建成植物表达载体pROK2-Rz和pROK2-mRz.采用转化下胚轴法转化油菜,通过筛选获得转Rz和mRz基因油菜植株、攻毒实验证明Rz当代转化植株表现出对CaMV的高度抗病性,75%的植株不表现任何症状,也测不出CaMV的存在,其抗病植株的T₁后代的抗病性按孟德尔定律3:1分离.mRz当代转化植株及其T₁后代植株只具有极其微弱的减轻症状的作用.     

脱氧核酶抑制近日基因period 1表达的实验研究

研究脱氧核酶对近日钟基因period1(per1)表达的影响, 进而寻找治疗和近日节律有关疾病的基因疗法. 设计合成针对per 1的脱氧核酶DRz164, DRz256, 并构建pcDNA3-per1_164:256体外转录载体, 将转录产物和脱氧核酶混合, 在一定反应条件下进行体外切割反应, 地高辛酶联免疫及酶催化显色法检测脱氧核酶的体外切割效率. 将pcDNA3-per1和DRz164或DRz256在脂质体的介导下转染NIH3T3细胞, 通过逆转录-聚合酶链反应(RT-PCR)、流式细胞术(FCM)检测脱氧核酶对近日基因表达的影响. 于37℃孵育2 h后, DRz164对底物的剪切百分率为63%, DRz256为50.5%. RT-PCR半定量检测per1 mRNA表达水平明显下降, FCM结果显示细胞内Per1蛋白的合成受到抑制. 脱氧核酶DRz164, DRz256体外具有定点切割近日钟基因per1mRNA组分的活性, 使转染细胞per1 mRNA 和Per1蛋白表达下降.     

特异切割苹果锈果类病毒的核酶基因的克隆和转录物的体外活性测定

根据锤头型核酶的作用模式 ,设计、合成和克隆了特异切割苹果锈果类病毒ASSVd正链 (194-196位点 )或负链 (89- 91位点 )RNA的 2个短臂锤头型核酶基因 :42nt的RzASSVd(+)和 40nt的RzASSVd(- )。经转录获得核酶转录物和³²P标记的ASSVd正、负链转录物。将核酶与ASSVd混合 ,50℃或 37℃保温 3～ 4h ,进行 8%PAGE(含8mol L尿素 )和放射自显影分析。体外切割检测表明 :2个核酶均具有特异切割活性 ,其中RzASSVd(- )对ASSVd负链的切割活性较高 ,对ASSVd正链不起作用。RzASSVd(+)对ASSVd正链的切割活性较弱 ,对ASSVd负链亦不起作用。在此基础上 ,构建得到双价核酶基因pGEMRzASSVd(± )。     

特异切割马铃薯纺锤形块茎类病毒负链的多价核酶的构建和体外活性测定

根据锤头型核酶的作用模式 ,设计、合成并克隆了特异切割马铃薯纺锤形块茎类病毒 (PSTVd)负链RNA不同区域位点的双价和三价锤头型核酶基因。通过体外转录 ,将PSTVd负链RNA分别与双价和三价核酶混合 ,37℃温育 2h。结果表明 ,双价核酶和三价核酶均表现出较高的切割活性 ,其中双价核酶处理的切割产物的大小与理论值相符合。三价核酶虽表现出较高的切割活性 ,但只是其中一价核酶在起作用。讨论了二价和三价核酶的应用前景。     

切割HPV-6bE1和HPV-11E1通用核酶Rz 1282的体外活性鉴定

利用计算机分析 HPV- 6b E1和 HPV- 1 1 E1 m RNA的同源序列 ,设计出通用于两者的锤头状核酶—— Rz1 2 82 (HPV- 6b基因 1 2 82位 ) ,通过体外转录建立了体外大量制备 Rz1 2 82的方法 .体外的切割实验表明 ,Rz1 2 82可在体外准确和有效地切割 HPV- 6b/1 1 E1靶 RNA,形成 2 68nt/52nt和 2 31 nt/52 nt大小的切割产物 .对于 HPV- 6b,Km和 kcat值分别为 1 3.8nmol/L和 0 .0 7min-1;对于 HPV- 1 1 ,Km 和 kcat值分别为 2 3.0 nmol/L和 0 .2 4 min-1.结果表明 ,体外制备的 Rz1 2 82具有较好的特异催化切割活性 ,并通用于 HPV- 6b及 HPV- 1 1 .它有望发展成为在细胞内有效抑制HPV- 6b/1 1 DNA复制的核酸药物 .     

特异切割马铃薯纺锤形块茎类病毒负链的多价核酶的构建和体外活 …

根据锤头型核酶的作用模式,设计、合成并克隆了特异切割马铃薯纺锤形块茎类病毒（ＰＳＴＶｄ）负链ＲＮＡ不同区域位点的双价和三价锤头型核酶基因。通过体外转录,将ＰＳＴＶｄ负链ＲＮＡ分别与双价和三价核酶混合,３７℃温育２ｈ。结果表明,双价核酶和三价核酶均表现出较高的切割活性,其中双价核酶处理的切割产物的大小与理论值相符合。三价核酶虽表现出较高的切割活性,但只是其中一价核酶在起作用,讨论了二价和三价核酶的应     

Effect of ribozyme against transforming growth factorbeta1 on biological character of activated HSCs

Transforming growth factorbeta1 (TGFbeta1) is considered to be the principal contributor to liver fibrosis. So in this study the ribozymes against TGFbeta1 were designed. The in vitro cleavage activities of the ribozymes were assayed through incubation of (32)p-labeled target RNAs and (32)p-labeled ribozymes in different conditions. HSC-T6 cells were transfected with the eukaryotic constructs encoding ribozyme and disable ribozyme, then the stable cell clones were used to evaluate its antifibrotic characteristic through the effect of ribozyme on biological character of activated hepatic stellate cells (HSCs). The results demonstrated that two ribozymes (Rz803 and Rz1395) could cleave target RNAs into expected products effectively, Rz803 possessed better cleavage activity in vitro. Stable transfection of Rz803 into activated HSCs reduced TGFbeta1 expression in mRNA and protein level efficiently. The further studies demonstrated that Rz803 reduced deposition of collagen I, suppressed HSC proliferation, but had no effect on HSC activation in transfected HSC-T6 cells. Therefore, it indicated that Rz803 could reverse the character of activated HSCs by down-regulating TGFbeta1 expression efficiently and diminishing TGFbeta1 signaling underlying activation of hepatic stellate cells. As the consequence, it would provide a potential therapeutic approach for liver fibrosis.     

Strategies for the suppression of peroxidase gene expression in tobacco. I. Designing efficient ribozymes

Five short hammerhead ribozymes (Rzs) were constructed and tested, using a range ofin vitro reaction conditions, for catalytic activity against the mRNA encoding the lignin-forming peroxidase (TPX) of tobacco. Although all 5 Rzs were shown to be able to cleave the RNA substrate, percentage cleavage varied with pre-denaturation of Rz and substrate, incubation temperature, length of incubation and ribozyme (Rz)-to-substrate ratio. One Rz with two catalytic units and 60 nucleotides of complementary sequence in 3 regions was shown to most efficiently cleave the substrate under allin vitro conditions tested. This ribozyme cleaved better than the two single ribozymes from which it was made. The superior cleaving ability of this Rz was shown to be due to the accessibility of the chosen target site and to the increased length of the hybridizing arms spanning this accessible region of the RNA.     

混合Ribozyme联合切割小鼠腺苷脱氨酶mRNA研究

采用计算机辅助设计得到针对小鼠腺苷脱氨酶ｍＲＮＡ的４种ｒｉｂｏｚｙｍｅ,它们均能在各自的切点切割ＲＮＡ分子,４种ｒｉｂｏｚｙｍｅ经组合后成混合ｒｉｂｏｚｙｍｅ,它们分别含有２种、３种和４种ｒｉｂｏｚｙｍｓ。通过对体外转录靶ＲＮＡ分子的联合切割研究表明,随着ｒｉｂｏｚｙｍｅ种数的增加,其中以（Ｒｚ２６２＋Ｒｚ４５５＋Ｒｚ５８３）组成最为理想,由此证明混合ｒｉｂｏｚｙｍｅ中,各种ｒｉｂｏｚｙｍｅ不仅保     

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

The structural motif formed between a hammerhead ribozyme and its substrate consists of three RNA double helices in which the sequence 5' to the XUY is termed helix I and the sequence 3' to the XUY helix III. Two hammerhead ribozymes targeted to the tat gene of HIV-1SF2 were designed to study target specificity and the potential effect of helix I mismatch on ribozyme efficacy both in vitro and in vivo. The first ribozyme (Rz1) targeted to the 5' splicing region of the tat gene was designed to cleave GUC*A. In HIV-1IIIB the A is changed to a G. The second ribozyme (Rz2) was targeted to the translational initiation region of the tat gene which is highly conserved among a variety of HIV-1 isolates, including both HIV-1SF2 and HIV-1IIIB. In vitro cleavage studies demonstrated that Rz1 efficiency cleaved HIV-1SF2 substrate RNA, but not HIV-1IIIB, presumably due to the base change from A to G. In contrast, Rz2 cleaved HIV-1SF2 or HIV-1IIIB substrate with equal efficiency. Both ribozymes were cloned into the 3' untranslated region of the neomycin gene (neo) within the pSV2neo vector and transfected into the SupT1 human CD4+ T cell line. Following selection, stable transfectants were challenged with either HIV-1SF2 or HIV-1IIIB virus. While Rz1-expressing cells were significantly protected from HIV-1SF2 infection, they exhibited no protection when infected with HIV-1IIIB virus. In contrast, Rz2 was effective in inhibiting the replication of both HIV-1SF2 and HIV-1IIIB in SupT1 cells. Expression of both ribozymes in these cells was demonstrated by Northern analysis. RT-PCR sequencing analysis confirmed the respective HIV-1 target sequence integrity. These data demonstrate the importance of the first base pair distal to the XUY within helix I of the hammerhead structure for both in vitro and in vivo ribozyme activities and imply that the effectiveness of the anti-HIV-1 ribozymes against appropriate target sequences is due to their catalytic activities rather than any antisense effect.     

双价核酶对烟草花叶病毒的两个靶序列的专一切割作用

报道了两个最简单的多价核酶即双价核酶RZ34和RZl3的构建和体外作用情况。实验结果表明,这两个双价核酶能分别对两个不同的TMV底物或其混合物施行专一切割。双价核酶对单十底物的作用效率与其相应的单价核酶相似。还就双价核酶内的单元核酶的相对位置对其专一性和作用效率的影响进行了探索。